In vitro combined effects of human interferons and interleukin-2 on natural cell-mediated cytotoxicity

This publication has 20 references indexed in Scilit:

• Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gamma
  Clinical and Experimental Immunology, 1990
• Autologous and allogenic natural cell mediated cytotoxicity at the single cell level: divergent effects of interferons and interleukin 2 on binding and lysis
  Cancer Letters, 1989
• The inhibitory effect of human interferon α on the generation of lymphokine-activated killer activity
  Cancer Immunology, Immunotherapy, 1989
• Activation of natural killer cells via the p75 interleukin 2 receptor.
  The Journal of Experimental Medicine, 1989
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer
  New England Journal of Medicine, 1987
• Interaction of recombinant interferons with recombinant interleukin-2: Differential effects on natural killer cell activity and interleukin-2-activated killer cells
  International Journal of Cancer, 1986
• Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
  The Journal of Experimental Medicine, 1982
• Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes
  Cellular Immunology, 1982
• Properties and usefulness of the original K-562 human myelogenous leukemia cell line
  Leukemia Research, 1979